Assignee
NINGBO T MAXIMUM BIOPHARMACEUTICALS CO LTD
CN·1 granted patent·3 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
4 records- 0149US12133890B2Antigen-binding polypeptide targeting B7H3 and application thereofNINGBO T MAXIMUM BIOPHARMACEUTICALS CO LTD·Filed 2022·Granted Nov 5, 2024·0 cites·26 claims
- 0247US2024376216A1Universal car-t cell targeting il13ralpha2, preparation method therefor and application thereofNINGBO T MAXIMUM BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0347US2024139321A1Universal car-t cell targeting gd2, preparation method therefor, and application thereofNINGBO T MAXIMUM BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0440US2025171550A1Bcma-targeting single-domain antibodyNINGBO T MAXIMUM BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NINGBO T MAXIMUM BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →